Therapeutic advances in neurodegeneration with brain iron accumulation.

@article{Zorzi2013TherapeuticAI,
  title={Therapeutic advances in neurodegeneration with brain iron accumulation.},
  author={Giovanna Zorzi and Nardo Nardocci},
  journal={International review of neurobiology},
  year={2013},
  volume={110},
  pages={
          153-64
        }
}
Neurodegeneration with brain iron accumulation (NBIA) includes a heterogeneous group of genetically defined progressive disorders with iron accumulation in the basal ganglia. Current conventional medical or surgical therapeutic options for these disorders remain unsatisfactory and do not prevent the disease to progress to a severe and most disabling condition for the patients. In the last decade, research has been focused on the role of iron in the pathophysiological process of these disorders… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 49 REFERENCES

life-threatening dystonia in a child with Hallervorden-Spatz disease

N. Boddaert, K. H. Le Quan Sang, A. Rötig, A. Leroy-Willig, S Gallet
  • Movement Disorders,
  • 2007
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Dystonia: medical therapy and botulinum toxin.

  • Advances in neurology
  • 2004
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Long term improvement under deferiprone in a case of neurodegenerationwith brain iron

A. Kwiatkowski, G. Ryckewaert, +4 authors F P.
  • accumulation. Parkinsonism&RelatedDisorders,
  • 2012
VIEW 2 EXCERPTS